Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2009 | 12-2008 | 09-2008 | 06-2008 | 03-2008 | |
Cash Flows From Operating Activities | |||||
Net Income | 1,313,100 | -2,071,900 | 1,557,500 | 2,023,100 | 1,064,300 |
Depreciation Amortization | 306,300 | 1,122,600 | 842,300 | 559,000 | 277,500 |
Income taxes - deferred | 129,100 | 442,600 | 268,000 | -41,500 | 111,900 |
Accounts receivable | N/A | 799,100 | N/A | N/A | N/A |
Accounts payable and accrued liabilities | N/A | -1,608,300 | N/A | N/A | N/A |
Other Working Capital | -672,000 | 924,200 | 144,000 | -51,300 | 70,200 |
Other Operating Activity | -988,600 | 7,687,300 | 2,103,300 | 294,200 | 178,700 |
Operating Cash Flow | $87,900 | $7,295,600 | $4,915,100 | $2,783,500 | $1,702,600 |
Cash Flows From Investing Activities | |||||
Change In Deposits | 286,200 | 957,600 | -237,300 | -730,700 | -715,700 |
PPE Investments | -157,000 | -921,500 | -671,500 | -450,600 | -184,200 |
Net Acquisitions | N/A | -6,083,000 | -44,400 | N/A | N/A |
Purchase Of Investment | -67,700 | -2,412,400 | -1,295,400 | -979,300 | -41,500 |
Sale Of Investment | 184,800 | 1,597,300 | 653,500 | 474,800 | 36,000 |
Other Investing Activity | -19,000 | -406,800 | -207,400 | -188,300 | -128,600 |
Investing Cash Flow | $227,300 | $-7,268,800 | $-1,802,500 | $-1,874,100 | $-1,034,000 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | -4,243,600 | 5,060,500 | -392,200 | -349,300 | -342,500 |
Debt Issued | 2,400,000 | 100 | -10,700 | -7,300 | 100 |
Debt Repayment | N/A | -649,800 | N/A | N/A | N/A |
Dividend Paid | -536,800 | -2,056,700 | -1,541,500 | -1,021,200 | -513,600 |
Other Financing Activity | 0 | -8,100 | -6,800 | -7,600 | -5,900 |
Financing Cash Flow | $-2,380,400 | $2,346,000 | $-1,951,200 | $-1,385,400 | $-861,900 |
Exchange Rate Effect | -118,400 | -96,600 | -28,300 | 123,800 | 118,200 |
Beginning Cash Position | 5,496,700 | 3,220,500 | 3,220,500 | 3,220,500 | 3,220,500 |
End Cash Position | 3,313,100 | 5,496,700 | 4,353,600 | 2,868,300 | 3,145,400 |
Net Cash Flow | $-2,183,600 | $2,276,200 | $1,133,100 | $-352,200 | $-75,100 |
Free Cash Flow | |||||
Operating Cash Flow | 87,900 | 7,295,600 | 4,915,100 | 2,783,500 | 1,702,600 |
Capital Expenditure | -157,000 | -947,200 | -671,500 | -450,600 | -184,200 |
Free Cash Flow | -69,100 | 6,348,400 | 4,243,600 | 2,332,900 | 1,518,400 |